• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Neurourology and urodynamics. >Pelvic floor biofeedback therapy in children: Assessment of symptom scores in responders and non-responders
【24h】

Pelvic floor biofeedback therapy in children: Assessment of symptom scores in responders and non-responders

机译：儿童骨盆底生物融产疗法：响应者和非响应者的症状分数评估

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction Pelvic Floor Biofeedback Therapy (PFBT) can be an effective treatment for pediatric lower urinary tract symptoms (LUTS). Due to differing perceptions of efficacy and practice patterns, we sought to further evaluate PFBT in our practice. We hypothesized that PFBT results in quiescence of EMG activity during voiding and improves questionnaire scores in patients with LUTS. Methods We retrospectively reviewed all patients undergoing PFBT and refined the analysis to females = 6 years old with = 2 sessions with completed voiding questionnaires pre- and post-treatment, active EMG during voiding, with non-neurogenic urinary tract complaints refractory to standard urotherapy. Validated Bladder Bowel Dysfunction (BBD) questionnaires were collected at each visit. Quiescence of EMG activity and changes in BBD score were the primary outcomes. Results 229 patients underwent = 1 PFBT session, of which 64 females = 6 years of age with = 2 PFBT sessions and completed pre and post PFBT voiding questionnaires were identified. In this group, mean age at PFBT start was 10.1 (6.2-17.0). Patients completed 3.1 sessions (2-6). No difference was seen in post-void residual (PVR) between first and last session (23.8 vs 22.6 mL, P = 0.55). Median questionnaire score decreased from 18 (4-42) before to 13 (2-28) following PFBT (P 0.0001). Responders, characterized by silencing of the EMG after PFBT, occurred in 31% (20/64). Non-responders were younger (P = 0.007) with higher pre-PFBT questionnaire scores. Conclusion The use of PFBT appears to result in a significant reduction in symptom scores, though quiescence of EMG was observed following therapy in less than 1/3 of patients.
机译：简介骨盆底生物融资疗法（PFBT）可以有效治疗儿科尿路症状（LUT）。由于对疗效和实践模式的看法不同，我们试图进一步评估PFBT在我们的实践中。我们假设PFBT在排尿期间产生EMG活动的静态，并改善LUT患者的问卷评分。方法回顾性地审查了所有接受PFBT的患者，并将分析对女性＆ = 6岁，= 2次，具有完成的排尿问卷预先治疗，活性EMG在排尿期间，非神经源性泌尿道投诉难治标准哺乳酸。在每次访问时收集验证的膀胱肠功能障碍（BBD）问卷。 EMG活动的静态和BBD评分的变化是主要结果。结果229例患者接受了＆ = 1个PFBT会议，其中64个女性＆ = 6岁，＆ = 2个PFBT会话和完成的预先和PFBT空缺问卷调查问卷。在这个组中，PFBT开始的平均年龄为10.1（6.2-17.0）。患者完成3.1次（2-6）。在第一和最后一次和最后一次会议之间的空隙后残留（PVR）中没有差异（23.8 Vs 22.6 ml，p = 0.55）。在PFBT（P <0.0001）之后，从18（4-42）之前的18（4-42）减少了中位数问卷评分。响应者，其特征在于PFBT后沉默EMG，发生在31％（20/64）中发生。非响应者更年轻（P = 0.007），PEPFBT预调查问卷评分更高。结论PFBT的使用似乎导致症状分数显着降低，但在不到1/3患者的治疗后观察到EMG的静态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号